GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and cancer drugs will make ...

London stocks were still a touch higher by midday on Wednesday as investors continued to mull the impact of Trump’s trade war ...

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.

GSK shares surge as the drugmaker raises its 2031 sales target to over £40bn, boosts dividends, and announces a £2bn share buyback plan.

Takeda CEO Christophe Weber announced he will step down in 2026 and be replaced by Julie Kim, president of Takeda’s U.S.

Julie Kim, currently Takeda’s U.S. head, will replace Weber in June 2026 and become one of the few female CEOs of a top ...

Mr. Finney brings 35 years of leadership, operations and corporate development experienceSOUTH SAN FRANCISCO, Calif., Jan. 28, 2025 (GLOBE ...

Nitin Sahney, co-founder and CEO of PharmaCord, poses for a portrait in the pharmaceutical support company’s new headquarters ...

Ferdinando most recently was vice president and global sector leader at Kimberly-Clark Corp. There, she led the global family ...

GlaxoSmithKline’s CEO Emma Walmsley has said the company hopes to get at least six new drug approvals in the next year. In an interview at the JP Morgan Healthcare Conference in San Francisco ...

TikTok CEO Shou Zi Chew plans to attend President-elect Donald Trump's inauguration on Monday as the company confronts a new law with a looming deadline requiring it to sell to a non-Chinese firm ...

TikTok CEO Shou Zi Chew will attend President-elect Trump’s inauguration Monday, one day after a potential ban of the video sharing platform could take effect in the U.S., according to a source ...